Could cell‐free DNA and host biomarkers assist in antimicrobial stewardship with organ transplant recipients?

Abstract

Background Antimicrobial stewardship in solid organ transplant (SOT) recipients is important to prevent antimicrobial‐associated complications, but traditional stewardship principles are challenging to implement for SOT patients. Newer methodologies to optimize stewardship efforts are needed. Methods PubMed was searched using the keywords “cell free DNA,” “metagenomic sequencing,” “host biomarker,” “antimicrobial stewardship,” and “SOT.” Results Metagenomic sequencing of cell free DNA has the potential to be a stewardship tool for SOT recipients. Various studies have shown its use for antimicrobial de‐escalation and duration shortening. Host gene expression profiles can differentiate between infectious and noninfectious syndromes and may assist in stewardship efforts. However, information in immunocompromised hosts is conflicting. Conclusion Microbial cell free DNA sequencing and host gene expression profiling show promise as stewardship tools in SOT recipients. Future studies on antimicrobial stewardship in SOT recipients should focus on their clinical use and feasibility.

Prevention, diagnosis, and management of donor derived infections in pediatric kidney transplant recipients

“…This also would result in improved antimicrobial stewardship in the SOT population. However, there are still unanswered questions about the challenges of interpretation in immunosuppressed individuals and further investigation is needed (73).…”